To explore whether miRNAs participate in IGF-1-mediated glioma cell sensitivity to TMZ treatment, we conducted an miRNA microarray analysis using cells treated with 200 ng/ml IGF-1 for 48 h. Here, IGF1 is linked to central nervous system cancer.